A 90 - day repeated dose oral gavage toxicity evaluation study of the combined myo-inositol product s-femme in Wistar rats
Nội dung chính của bài viết
Tóm tắt
In the present study, a sub-chronic oral toxicity study was designed to assess the safety of S-FEMME powder in Wistar rats. The 90-day toxicity study was conducted by oral administration at doses of 0 (control), 0.12, and 0.36 sachets/kg/day for a continuous period of 90 days in Wistar rats. The evaluated parameters included body weight, clinical observations, hematological and biochemical analyses, gross necropsy, and histopathological assessment. The findings demonstrated that oral exposure to S-FEMME at both dose levels did not induce any clinical sign, no mortality, toxicologically significant changes in hematology, clinical biochemistry, macroscopic findings, or histopathological examination. In summary, the no-observed-adverse-effect-level (NOAEL) of S-FEMME is greater than 0.36 sachets/kg/day when administered orally for 90 consecutive days at two doses in Wistar rats.
Chi tiết bài viết
Từ khóa
S-FEMME, repeated dose toxicity, experimental animals
Tài liệu tham khảo
2. WHO (World Health Organization). Infertility Prevalence Estimates, 1990-2021. 1st ed. World Health Organization; 2023.
3. Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006; 12(6): 685-718. doi:10.1093/humupd/dml034.
4. Legro R, Brzyski R, Diamond M, et al. Letrozole Versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. The New England journal of medicine. 2014; 371: 119-129. doi:10.1056/NEJMoa1313517.
5. Unfer V, Nestler JE, Kamenov ZA, et al. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016; 2016: 1849162. doi:10.1155/2016/1849162.
6. Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012; 10: 49. doi:10.1186/1477-7827-10-49.
7. Wilma F. Bergfeld; Donald V. Belsito; David E. Cohen, et al. Safety Assessment of Inositol as Used in Cosmetics. 2024.
8. Bellamine A, Durkee S. Genotoxicity and subchronic oral toxicity studies of L-carnitine and L-carnitine L-tartrate. Journal of Drug Metabolism & Toxicology. 2021; 12(1): 1-12.
9. Sawamura H, Fukuwatari T, Shibata K. Effects of excess biotin administration on the growth and urinary excretion of water-soluble vitamins in young rats. Biosci Biotechnol Biochem. 2007; 71(12): 2977-2984. doi:10.1271/bbb.70381.
10. Abdo KM, Rao G, Montgomery CA,et al. Thirteen-week toxicity study of d-alpha-tocopheryl acetate (vitamin E) in Fischer 344 rats. Food Chem Toxicol. 1986; 24(10-11): 1043-1050. doi:10.1016/0278-6915(86)90287-5.
11. Hrubša M, Siatka T, Nejmanová I, et al. Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5. Nutrients. 2022; 14(3): 484. doi:10.3390/nu14030484.
12. OECD. Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents. OECD Guidelines for the Testing of Chemicals, Section 4. Published online June 24, 2025. doi:10.1787/9789264070707-en.
13. Abdulwahid SJ, Goh MY, Ebrahimi M, et al.Sub-acute oral toxicity profiling of the methanolic leaf extract of Clinacanthus nutans in male and female ICR mice. Int J Pharm Pharm Sci. 2018; 10(12): 25. doi:10.22159/ijpps.2018v10i12.28075.
14. Asyura S, Hazilawati H, Shaari R, et al. Blood Profiles and Histopathological Changes of Liver and Kidney Tissues from Male Sprague Dawley Rats Treated with Ethanol Extracts of Clinacanthus nutans Leaf. Journal of Clinical Toxicology. 2016; 06. doi:10.4172/2161-0495.1000329.
15. Carlomagno G, Unfer V. Inositol safety: clinical evidences. Eur Rev Med Pharmacol Sci. 2011; 15(8): 931-936.
16. World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Published online December 31, 2007:105.
17. De Jong WH, Carraway JW, Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. In: Biocompatibility and Performance of Medical Devices. Elsevier; 2020: 123-166. doi:10.1016/B978-0-08-102643-4.00007-0.